| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973022 | The Journal of Heart and Lung Transplantation | 2006 | 9 Pages |
Abstract
Heart transplant recipient risk may be modified by vaccination against hepatitis B before transplantation. There is currently no available vaccine for hepatitis C. Recently described effective treatments for hepatitis B and hepatitis C provide further rationale for reconsideration of using hearts from donors with evidence of hepatitis B and/or hepatitis C infection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Steven D. MD, Robin K. MD,